Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 8/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.71 |
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | HPGD | P15428 | 3/20 | 0.71 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 1/20 | 0.71 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.71 |
| ▸ | RELA | Q04206 | 1/20 | 0.71 |
| ▸ | ATM | Q13315 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | ACACA | Q13085 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29788461 | 1.00 | DHODH (0.81) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL12273377 | 0.91 | DHODH (0.80) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL8240361 | 0.90 | DHODH (0.70) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL9865641 | 0.90 | DHODH (0.70) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL28576456 | 0.89 | DHODH (0.69) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL13056561 | 0.88 | DHODH (0.71) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL20118104 | 0.88 | DHODH (0.67) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL29674931 | 0.87 | RAB9A (0.70) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL4602056 | 0.87 | RAB9A (0.70) | DHODHKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL9867633 | 0.87 | DHODH (0.80) | DHODHKMT2AKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260056191-A1 | POLYMERS AND CONJUGATES COMPRISING THE SAME | VENTANA MEDICAL SYSTEMS, INC. (US) | 2026-02-26 | — | — | US | claimed |
| US-11079372-B2 | Polymers and conjugates comprising the same | VENTANA MEDICAL SYSTEMS, INC. (US) | 2021-08-03 | — | — | US | claimed |
| EP-3201628-A2 | POLYMERS AND CONJUGATES COMPRISING THE SAME | Ventana Medical Systems, Inc. (US) | 2017-08-09 | — | — | EP | claimed |
| US-20170205399-A1 | POLYMERS AND CONJUGATES COMPRISING THE SAME | VENTANA MEDICAL SYSTEMS, INC. | 2017-07-20 | — | — | US | claimed |
| WO-2016050913-A2 | POLYMERS AND CONJUGATES COMPRISING THE SAME | VENTANA MEDICAL SYSTEMS, INC. (US) | 2016-04-07 | — | — | WO | claimed |
| EP-2444806-A2 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | Ventana Medical Systems, Inc. (US) | 2012-04-25 | — | — | EP | claimed |
| US-20100297725-A1 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | VENTANA MEDICAL SYSTEMS, INC. | 2010-11-25 | — | — | US | claimed |
| US-20100184087-A1 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | VENTANA MEDICAL SYSTEMS, INC. | 2010-07-22 | — | — | US | claimed |
| WO-2010020672-A1 | NOVEL PHENYL-QUINOLINE-CARBOXYLIC ACID PYRIDINE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | NEUROSEARCH A/S (DK) | 2010-02-25 | — | — | WO | claimed |
| EP-2078197-A2 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | Ventana Medical Systems, Inc. (US) | 2009-07-15 | — | — | EP | claimed |
| US-20080268462-A1 | Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits | VENTANA MEDICAL SYSTEMS, INC. | 2008-10-30 | — | — | US | claimed |
| WO-2008063378-A9 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC (US) | 2008-07-31 | — | — | WO | claimed |
| WO-2008063378-A2 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-05-29 | — | — | WO | claimed |
| US-20260056191-A1 | POLYMERS AND CONJUGATES COMPRISING THE SAME | VENTANA MEDICAL SYSTEMS, INC. (US) | 2026-02-26 | — | — | US | disclosed |
| US-12553886-B2 | Polymers and conjugates comprising the same | VENTANA MEDICAL SYSTEMS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-20250066426-A1 | PEPTIDE NUCLEIC ACID CONJUGATES | VENTANA MED SYST INC (US) | 2025-02-27 | — | — | US | disclosed |
| US-20070197509-A1 | Compositions and methods for modulating gated ion channels | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-08-23 | — | — | US | disclosed |
| US-20070197509-A1 | Compositions and methods for modulating gated ion channels | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-08-23 | — | — | US | disclosed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
| US-5071987-A | Quinoline dyes; colorfastness | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268462-A1 | Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits | HRH4, CRBN, NCDN | DHODH 1077/4885KMT2A 3827/4885KDM4E 3532/4885 |
| US-12553886-B2 | Polymers and conjugates comprising the same | POLL, INCENP, POLI | DHODH 358/4885KMT2A 1495/4885KDM4E 2159/4885 |
| US-20260056191-A1 | POLYMERS AND CONJUGATES COMPRISING THE SAME | POLD1, POLL, INCENP | DHODH 415/4885KMT2A 1085/4885KDM4E 1567/4885 |
| US-20100297725-A1 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | CRBN, GABBR1, SHBG | DHODH 1439/4885KMT2A 3542/4885KDM4E 3907/4885 |
| US-20070060573-A1 | Acyltryptophanols | FSHR, NPY1R, NPY2R | DHODH 3439/4885KMT2A 916/4885KDM4E 2399/4885 |
| US-20070197509-A1 | Compositions and methods for modulating gated ion channels | KCNN3, KCNN2, HCN3 | DHODH 3771/4885KMT2A 2807/4885KDM4E 2625/4885 |
| US-20250066426-A1 | PEPTIDE NUCLEIC ACID CONJUGATES | PCNA, PARG, POLL | DHODH 4561/4885KMT2A 1725/4885KDM4E 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.